Gland Pharma (NSE:GLAND) Change In Inventory : ₹0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gland Pharma Change In Inventory?

Gland Pharma's change in inventory for the quarter that ended in Mar. 2024 was ₹0 Mil. It means Gland Pharma's inventory stayed the same from Dec. 2023 to Mar. 2024 .

Gland Pharma's change in inventory for the fiscal year that ended in Mar. 2024 was ₹6,661 Mil. It means Gland Pharma's inventory declined by ₹6,661 Mil from Mar. 2023 to Mar. 2024 .

Gland Pharma's Total Inventories for the quarter that ended in Mar. 2024 was ₹16,552 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Gland Pharma's Days Inventory for the quarter that ended in Mar. 2024 was 126.00.

Inventory Turnover measures how fast the company turns over its inventory within a year. Gland Pharma's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.72.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Gland Pharma's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.54.

Gland Pharma Change In Inventory Historical Data

The historical data trend for Gland Pharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gland Pharma Change In Inventory Chart

Gland Pharma Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Inventory

Get a 7-Day Free Trial

1,555.97

-5,188.89

895.01

-7,596.33

6,660.77

Gland Pharma Quarterly Data
	Mar19	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Gland Pharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Gland Pharma (NSE:GLAND) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Gland Pharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	8276.185	/	5993.82	*	365 / 4
	=	126.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Gland Pharma's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	5993.82	/	8276.185
	=	0.72

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Gland Pharma's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	8276.185	/	15374.5
	=	0.54

Gland Pharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of Gland Pharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Gland Pharma (NSE:GLAND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gland Pharma Ltd (NSE:GLAND) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

543245:India

Address

Plot No. 11 and 84, TSIIC Phase: IV, Pashamylaram (V), Patancheru (M), Sangareddy District, Hyderabad, TG, IND, 502307

Website

https://www.glandpharma.com

Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Further, the group is involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.

Gland Pharma (NSE:GLAND) Headlines

No Headlines